NCT03015129
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer treatment 2 completed NCT05112601
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma treatment 2 recruiting NCT05554328
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial treatment 2 recruiting NCT05564377
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial screening 2 recruiting NCT05691504
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers treatment 1 recruiting NCT06518564
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer (Prior IO) treatment 2 not_yet_recruiting NCT04469764
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer treatment 2 recruiting NCT00301964
Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT01198184
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT03586661
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 active_not_recruiting NCT04781088
Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 active_not_recruiting NCT03968406
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers treatment 1 recruiting NCT00462826
VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT04906382
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer treatment 0 terminated NCT01652794
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer treatment 1 completed NCT01764789
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer No drug interventions supportive_care Not Available completed NCT00025467
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT02093546
Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 No drug interventions Not Available Not Available completed NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) treatment 1 completed NCT01689714
Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma No drug interventions other 2 completed NCT05192850
Endometrial Cancer Recurrence in Patients Taking Metformin Not Available Not Available active_not_recruiting NCT06502743
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer treatment 2 not_yet_recruiting NCT00095979
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT00096447
Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT03924245
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers treatment 1 terminated NCT01079832
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies No drug interventions treatment 2 completed NCT03508570
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis treatment 1 active_not_recruiting NCT03367741
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer treatment 2 active_not_recruiting NCT05997017
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer treatment 2 recruiting NCT03120624
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer treatment 1 active_not_recruiting NCT01943058
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer treatment 2 withdrawn NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT00028535
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors treatment 1 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT00072176
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer treatment 2 completed NCT05523440
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation treatment 2 recruiting NCT03914612
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer treatment 3 active_not_recruiting NCT05603910
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma treatment 1 recruiting NCT00723255
Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer treatment 2 completed NCT00408655
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT03008408
A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma treatment 2 active_not_recruiting